GlassScriptPhysician profile
Meredith R Baker
NPI 1316161680
$2,026.61
in general payments reported to CMS, 2019-2025
22 companies · $621 in 2025
The $621 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $262 · 2020: $78.13 · 2021: $112 · 2022: $63.51 · 2023: $344 · 2024: $546 · 2025: $621.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343 · Education: $167.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.42 |
| Education | $166.79 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valencia Technologies Corporation | $379.00 | 2023-2025 | Ecoin Device Kit |
| Abbvie INC. | $286.88 | 2023-2025 | Botox |
| Astellas Pharma US INC | $261.93 | 2021-2023 | |
| Sumitomo Pharma America, INC. | $232.68 | 2023-2025 | Gemtesa |
| Dendreon Pharmaceuticals LLC | $168.00 | 2019 | |
| Procept Biorobotics Corporation | $98.83 | 2019-2025 | Aquabeam System |
| Medtronic, INC. | $98.80 | 2024 | Interstim |
| Medtronic USA, INC. | $63.00 | 2020 | |
| Janssen Biotech, INC. | $59.79 | 2024-2025 | Erleada |
| Coloplast Corp | $58.85 | 2022-2025 | |
| Myriad Genetic Laboratories, INC. | $49.72 | 2021-2023 | Prolaris |
| Urogen Pharma, INC. | $49.56 | 2022-2025 | |
| Accord Healthcare, INC. | $46.56 | 2024-2025 | |
| Teleflex LLC | $35.40 | 2023 | Urolift |
| 180 Medical, INC. | $24.35 | 2019 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Calyxo, INC. | $20.23 | 2025 | Cvac Aspiration System |
| Edap Technomed INC | $19.25 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $18.48 | 2025 | |
| Angiodynamics, INC. | $16.67 | 2023 | Nanoknife |
| Boston Scientific Corporation | $15.50 | 2025 | Axonics |
| Neotract INC. | $15.13 | 2020 | |
| Travere Therapeutics, INC. | $8.00 | 2019-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Meredith Baker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.